Editorial: Risks and Benefits of Adjuvants to Cancer Therapies

• Peixin Dong,
• David A. Gewirtz,
• David A. Gewirtz

Affiliations

Peixin Dong

Department of Obstetrics and Gynecology, Hokkaido University School of Medicine, Hokkaido University, Sapporo, Japan

David A. Gewirtz

Department of Pharmacology & Toxicology, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United States

David A. Gewirtz

Department of Medicine, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United States